share_log

Guggenheim Initiates Coverage On Zura Bio With Buy Rating, Announces Price Target of $20

Guggenheim Initiates Coverage On Zura Bio With Buy Rating, Announces Price Target of $20

古根海姆以买入评级开始对Zura Bio的报道,宣布目标价为20美元
Benzinga ·  2023/06/22 09:28

Guggenheim analyst Yatin Suneja initiates coverage on Zura Bio (NASDAQ:ZURA) with a Buy rating and announces Price Target of $20.

古根海姆分析师Yatin Suneja以买入评级开始对Zura Bio(纳斯达克股票代码:ZURA)进行报道,并宣布目标股价为20美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发